Jim Cramer shared his opinions on several stocks during CNBC's 'Mad Money Lightning Round'. He stated that MicroStrategy is a Bitcoin play, but he prefers to own Bitcoin directly. He also expressed his positive view on Oscar Health due to its CEO Mark Bertolini, and his negative views on CNH Industrial and B&G Foods. Additionally, he commented on Rocket Lab, saying it's a speculative investment. Cramer's comments were accompanied by the latest earnings reports and stock price movements for each company.
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
On CNBC's “ Mad Money Lightning Round ,” Jim Cramer said MicroStrategy Incorporated (NASDAQ: MSTR ) is a Bitcoin play and he prefers to actually own Bitcoin (CRYPTO: BTC ).
MicroStrategy announced it completed its previously announced offering of its 0% convertible senior notes due 2029. MicroStrategy said the aggregate principal amount of the notes sold in the offering was $3 billion, which includes $400 million aggregate principal amount of notes issued pursuant to an option to purchase.
When asked about Oscar Health, Inc . (NYSE: OSCR ), he said, “Until I saw that Mark Bertolini is the CEO, I didn't really have much in store for this. But Bertolini's a winner and a hitter.”
Don’t Miss:
On Nov. 7, Oscar Health reported a quarterly loss of 22 cents per share which missed the analyst consensus estimate of a loss of 19 cents per share. The company reported quarterly sales of $2.42 billion which beat the analyst consensus estimate of $2.34 billion.
CNH Industrial N.V. (NYSE: CNH ) is a “second-rater,” Cramer said. “I want to go with best of breed, and best of breed is John Deere (NYSE: DE ).”
On Nov. 7, CNH Industrial reported worse-than-expected third-quarter EPS results and also lowered FY24 adjusted EPS outlook.
“The former, BGS, is a total loser and has been a loser for many, many years,” Cramer said when asked about B&G Foods, Inc. (NYSE: BGS ).
On Nov. 5, B&G Foods reported worse-than-expected third-quarter financial results and issued FY24 net sales guidance below estimates.
When asked about Rocket Lab USA, Inc . (NASDAQ: RKLB ), he said, “It's moth to flame, but I don't know how close the moth is to the flame.”
On Nov. 19, Goldman Sachs analyst Noah Poponak maintained Rocket Lab with a Neutral and raised the price target from $5 to $12.
Price Action:
Check It Out:
A 9% Return In Just 3 Months
EquityMultiple's ‘Alpine Note — Basecamp Series' is turning heads and opening wallets. This short-term note investment offers investors a 9% rate of return (APY) with just a 3 month term and $5K minimum. The Basecamp rate is at a significant spread to t-bills. This healthy rate of return won't last long. With the Fed poised to cut interest rates in the near future, now could be the time to lock in a favorable rate of return with a flexible, relatively liquid investment option.
What's more, Alpine Note — Basecamp can be rolled into another Alpine Note for compounding returns, or into another of EquityMultiple's rigorously vetted real estate investments, which also carry a minimum investment of just $5K. Basecamp is exclusively open to new investors on the EquityMultiple platform. Looking for fractional real estate investment opportunities? The Benzinga Real Estate Screener features the latest offerings.
Image: Shutterstock
This article Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin originally appeared on Benzinga.com